248 related articles for article (PubMed ID: 20381558)
1. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
Philippi C; Loretz B; Schaefer UF; Lehr CM
J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
3. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
4. Telomerase as a diagnostic and therapeutic target for cancer.
Doyle LA; Highsmith WE
Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
6. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
7. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
8. Telomere-based cancer treatment: emerging targeted therapies.
Chen M; McLeskey SW
Clin J Oncol Nurs; 2010 Dec; 14(6):720-6. PubMed ID: 21112850
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
11. Telomerase as an anti-cancer drug target: will it fulfil its early promise?
Newbold RF
Anticancer Drug Des; 1999 Aug; 14(4):349-54. PubMed ID: 10625927
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent.
Gryaznov SM; Jackson S; Dikmen G; Harley C; Herbert BS; Wright WE; Shay JW
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1577-9. PubMed ID: 18066830
[TBL] [Abstract][Full Text] [Related]
15. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
16. Telomeres rather than telomerase a key target for anti-cancer therapy?
Boukamp P; Mirancea N
Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
18. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Keith WN; Bilsland A; Hardie M; Evans TR
Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
Naasani I; Seimiya H; Tsuruo T
Biochem Biophys Res Commun; 1998 Aug; 249(2):391-6. PubMed ID: 9712707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
